These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Subgroups among mu-opioid receptor agonists distinguished by ATP-sensitive K+ channel-acting drugs. Ocaña M, Del Pozo E, Barrios M, Baeyens JM. Br J Pharmacol; 1995 Mar; 114(6):1296-302. PubMed ID: 7620721 [Abstract] [Full Text] [Related]
3. ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides. Lohmann AB, Welch SP. Eur J Pharmacol; 1999 Dec 03; 385(2-3):119-27. PubMed ID: 10607867 [Abstract] [Full Text] [Related]
4. Activation of central ATP-sensitive potassium channels produces the antinociception and spinal noradrenaline turnover-enhancing effect in mice. Narita M, Takamori K, Kawashima N, Funada M, Kamei J, Suzuki T, Misawa M, Nagase H. Psychopharmacology (Berl); 1993 Dec 03; 113(1):11-4. PubMed ID: 7862815 [Abstract] [Full Text] [Related]
9. Tolerance to delta- but not mu-opioid receptors in the spinal cord attenuates inhibition of the tail-flick response induced by beta-endorphin administered intracerebroventricularly in mice. Suh HH, Tseng LF. Pharmacol Biochem Behav; 1990 Apr 03; 35(4):807-13. PubMed ID: 2161107 [Abstract] [Full Text] [Related]